Efficacy and Safety of GLP-1 Receptor Agonists in Parkinson’s Disease: A Meta-Analysis Integrating the 96-Week Phase 3 Exenatide Trial Results
Objective: To evaluate the efficacy and safety of glucagon-like peptide-1 receptor agonists in patients with Parkinson’s disease (PD) through an updated systematic review and meta-analysis…Occupational Solvent Exposure and Parkinson’s Disease: An Observational Study in PPMI Online
Objective: To investigate the association between occupational solvent exposure and Parkinson’s disease using data from the PPMI Online cohort. Background: Environmental toxicant exposure has been…What Non-Genetic Parkinson’s Disease Risk Factors are Africans Exposed To? A Scoping Review
Objective: We set out to catalogue the risk factors patients with Parkinson’s Disease (PD) in Africa are exposed to. Background: Parkinson's disease (PD) is recognized…Social Network Structure and Caregiving Experiences in South Asian Families Living with Dementia Associated with Parkinsonian Disorders
Objective: To characterize social network structure and caregiving among SA families with Parkinsonian dementia (PD) and compare them with White American (WA) caregiving networks. Background:…Perioperative and Longitudinal Outcomes Following Deep Brain Stimulation in Patients with Movement Disorders: A Retrospective Review From a Movement Disorder Program
Objective: To evaluate postoperative symptoms improvement and quality-of-life outcomes in patients with movement disorders following deep brain stimulation (DBS). Background: Deep brain stimulation is an…Iron-independent initiation of neurodegeneration in BPAN
Objective: Beta-propeller protein–associated neurodegeneration (BPAN) is caused by mutations in WDR45 and classified within the neurodegeneration with brain iron accumulation (NBIA) spectrum. Although brain iron…Telemedicine in Parkinson’s Disease Management: Lessons from Resource-Limited Settings Like Nepal
Objective: To evaluate the feasibility, clinical outcomes, and patient satisfaction of telemedicine-based Parkinson’s disease management in Nepal. Background: Parkinson’s disease (PD) is a chronic neurodegenerative…Sex Differences in the Reported Prodromal Symptoms of Parkinson’s Disease (PD) in the Fox Insight Cohort
Objective: To identify differences in the self-reported prodromal symptoms of male vs female persons with PD (PwPD) in the Fox Insight (FI) cohort. Background: Early…Beyond Freezing of Gait Episodes in Parkinson’s Disease: Intercritical Kinematic Gait Pattern Matters.
Objective: To search for features discriminating different gait patterns during intercritical FOG-free phases in patients with anamnestic FOG, using spatiotemporal and kinematic variables and machine…Video-Based Gait Analysis for Objective Assessment of Motor Severity and Surgical Outcome in Parkinson’s Disease: A Scalable Alternative to Subjective Rating
Objective: To evaluate the accuracy of a gait-focused video analysis model in predicting clinical scores and post-surgical improvement in Parkinson’s disease (PD) Background: The MDS-UPDRS…
- « Previous Page
- 1
- …
- 102
- 103
- 104
- 105
- 106
- …
- 553
- Next Page »